Kathryn Kovalycsik, PharmD, Author at MPR

Kathryn Kovalycsik, PharmD

All articles by Kathryn Kovalycsik, PharmD

Comparison of Oral Therapies for C. difficile-Associated Diarrhea: Vancomycin Superior

A post-hoc analysis of data pooled from the largest multicenter, randomized, double-blinded, head-to-head clinical trials to date involving patients with Clostridium difficile-associated diarrhea treated with oral vancomycin and oral metronidazole presented at IDWeek 2012 has shown statistically superior clinical success with oral vancomycin.

Fluconazole Prophylaxis Effective in Preventing Invasive Candida Infections in High-Risk Preterm Infants

David A. Kaufman, MD, from the University of Virginia, presented study findings at IDWeek 2012 that showed targeted prophylaxis of fluconazole in infants <1,000g or ≤27 weeks using a 3mg/kg twice-weekly dose with a different antifungal used for treatment is effective in preventing invasive Candida infections.

Treatment and Outcomes of VTE in Children with Staphylococcus aureus Osteomyelitis

For children with Staphylococcus aureus osteomyelitis, the presence of venous thromboembolism is associated with a higher C-reactive protein at admission, longer hospital stay, and ICU admission, according to Kavita Patel, MD, from Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, at IDWeek 2012.